These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8786170)

  • 21. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
    Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
    Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dialysis membrane biocompatibility: effects on cellular elements.
    Coli L; De Sanctis LB; Feliciangeli G; Iannelli S; Scolari MP; Todeschini P; Tumietto F; Costigliola P; Chiodo F
    Nephrol Dial Transplant; 1995; 10 Suppl 10():27-32. PubMed ID: 8825429
    [No Abstract]   [Full Text] [Related]  

  • 23. Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia.
    Wegmüller E; Montandon A; Nydegger U; Descoeudres C
    Int J Artif Organs; 1986 Mar; 9(2):85-92. PubMed ID: 3699914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 25. Biocompatibility of dialysis membranes.
    Salem M; Ivanovich P; Mujais S
    Contrib Nephrol; 1993; 103():55-64. PubMed ID: 8354063
    [No Abstract]   [Full Text] [Related]  

  • 26. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of dialyzer biocompatibility in acute renal failure.
    Vanholder R; De Vriese A; Lameire N
    Blood Purif; 2000; 18(1):1-12. PubMed ID: 10686437
    [No Abstract]   [Full Text] [Related]  

  • 28. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reuse of haemodialysers.
    Shaldon S
    Nephrol Dial Transplant; 1994; 9(9):1226-7. PubMed ID: 7816280
    [No Abstract]   [Full Text] [Related]  

  • 30. Platelet and leucocyte behaviour during haemodialysis.
    Hoenich NA
    Contrib Nephrol; 1999; 125():120-32. PubMed ID: 9895436
    [No Abstract]   [Full Text] [Related]  

  • 31. Biocompatibility of haemodialysis membranes.
    van Berlo A; Ellens DJ
    Adv Exp Med Biol; 1988; 238():341-58. PubMed ID: 3074642
    [No Abstract]   [Full Text] [Related]  

  • 32. Recent advances in the biocompatibility of haemodialysis membranes.
    Hakim RM
    Nephrol Dial Transplant; 1995; 10 Suppl 10():7-11. PubMed ID: 8825426
    [No Abstract]   [Full Text] [Related]  

  • 33. Haemodialysis-induced leucopenia and activation of complement: effects of different membranes.
    Aljama P; Bird PA; Ward MK; Feest TG; Walker W; Tanboga H; Sussman M; Kerr DN
    Proc Eur Dial Transplant Assoc; 1978; 15():144-53. PubMed ID: 740661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of haemodialysis on coagulation and platelets: are we measuring membrane biocompatibility?
    Ward RA
    Nephrol Dial Transplant; 1995; 10 Suppl 10():12-17. PubMed ID: 8825427
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of dialyzer biocompatibility in acute renal failure.
    Schiffl H
    Blood Purif; 2001; 19(1):70-2. PubMed ID: 11114581
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased soluble CD14 levels in patients on hemodialysis. Influence of dialysate endotoxin or incompatibility to dialyzer membranes?
    Mitzner S; Stange J; Pichel K; Handschuk I; Korten G; Ehlers M; Schutt C; Schmidt R
    ASAIO J; 1995; 41(3):M707-8. PubMed ID: 8573897
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta 2-microglobulin associated amyloidosis and therapy with high flux hemodialysis membranes.
    Floege J; Koch KM
    Clin Nephrol; 1994 Jul; 42 Suppl 1():S52-6. PubMed ID: 7923985
    [No Abstract]   [Full Text] [Related]  

  • 38. Abnormal leucocyte locomotion induced by haemodialysis membranes. A clue to dialysis leucopenia.
    Losito A; Buoncristiani U; Cecchini C
    J Clin Lab Immunol; 1983 Feb; 10(2):87-90. PubMed ID: 6601717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
    Orłowski A; Szepietowski T
    Polim Med; 1992; 22(1-2):59-72. PubMed ID: 1461837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of bioincompatibility in dialysis morbidity and mortality.
    Lazarus JM; Owen WF
    Am J Kidney Dis; 1994 Dec; 24(6):1019-32. PubMed ID: 7985663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.